NasdaqCM - Nasdaq Real Time Price USD

Venus Concept Inc. (VERO)

2.3175
+0.1175
+(5.34%)
As of 12:30:34 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
64,833
64,833
--
99,497
105,622
Cost of Revenue
20,527
20,527
--
33,526
31,528
Gross Profit
44,306
44,306
--
65,971
74,094
Operating Expense
71,490
71,490
--
100,847
91,636
Operating Income
-27,184
-27,184
--
-34,876
-17,542
Net Non Operating Interest Income Expense
-7,656
-7,656
--
-4,561
-4,955
Other Income Expense
-12,742
-12,742
--
-4,869
-351
Pretax Income
-47,582
-47,582
--
-44,306
-22,848
Tax Provision
-611
-611
--
-722
-707
Net Income Common Stockholders
-46,996
-46,996
--
-43,700
-23,013
Diluted NI Available to Com Stockholders
-46,996
-46,996
--
-43,700
-23,013
Basic EPS
-71.21
-71.21
-68.47
-108.90
-69.30
Diluted EPS
-71.21
-71.21
-68.47
-108.90
-69.30
Basic Average Shares
659.9990
659.9990
543.9990
399.7570
330.0960
Diluted Average Shares
659.9990
659.9990
543.9990
399.7570
330.0960
Total Operating Income as Reported
-27,184
-27,184
--
-34,876
-14,767
Rent Expense Supplemental
3,249
3,249
4,312
9,435
10,459
Total Expenses
92,017
92,017
--
134,373
123,164
Net Income from Continuing & Discontinued Operation
-46,996
-46,996
--
-43,700
-23,013
Normalized Income
-34,417.6199
-34,417.6199
--
-38,910.3441
-22,672.8612
Interest Expense
7,656
7,656
--
4,561
4,955
Net Interest Income
-7,656
-7,656
--
-4,561
-4,955
EBIT
-39,926
-39,926
--
-39,745
-17,893
EBITDA
-36,037
-36,037
--
-35,282
-13,039
Reconciled Cost of Revenue
20,527
20,527
--
33,526
31,528
Reconciled Depreciation
3,889
3,889
--
4,463
4,854
Net Income from Continuing Operation Net Minority Interest
-46,996
-46,996
--
-43,700
-23,013
Total Unusual Items Excluding Goodwill
-12,742
-12,742
--
-4,869
-351
Total Unusual Items
-12,742
-12,742
--
-4,869
-351
Normalized EBITDA
-23,295
-23,295
--
-30,413
-12,688
Tax Rate for Calcs
0
0
--
0
0
Tax Effect of Unusual Items
-163.6199
-163.6199
--
-79.3441
-10.8612
12/31/2021 - 10/12/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NAOV NanoVibronix, Inc.
1.2350
-4.99%
 
BJDX Bluejay Diagnostics, Inc.
1.8900
-2.07%
 
RSLS ReShape Lifesciences Inc.
6.35
-1.85%
 
TIVC Tivic Health Systems, Inc.
4.5500
+6.12%
 
ADGM Adagio Medical Holdings, Inc.
1.1800
-2.47%
 
TNON Tenon Medical, Inc.
1.1250
+0.45%
 
IVF INVO Fertility, Inc.
2.2400
+3.23%
 
ALUR Allurion Technologies Inc.
3.2171
+5.15%
 
LFWD Lifeward Ltd.
1.2500
-3.10%
 
APYX Apyx Medical Corporation
1.4700
-1.34%